CoChat

An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications

Open access
Dunn, Evan N., Sheth, Veeral S., Hariprasad, Seenu M. · 2017 · Ophthalmic Surgery, Lasers and Imaging Retina
Cited by 70

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The vitreoretinal community will remember 2016 as the year that unfavorable anti–platelet-derived growth factor (anti-PDGF) clinical trial results ended the development of Fovista (pegpleranib; Ophthotech, New York, NY) and Rinucumab (Regeneron, Tarrytown, NY). The failure of these trials reaffirmed how important the innovations made in 2006 with anti-vascular endothelial growth factor (anti-VEGF) were to our field and our patients.\n\nEvan N. Dunn, MD, and Veeral S. Sheth, MD, were tasked with analyzing and dissecting the anti-PDGF clinical trials — beginning with the basic science behind anti-PDGF. They will also review novel, multitarget approaches to our diseases, as well as unique routes of delivery such as topical and suprachoroidal administration.\n\nReading this article leads one to appreciate how high the anti-VEGF class of molecules has set the bar for the treatment of vitreoretinal disease. Although recent clinical trial results have been a disappointment to our community (and our patients), we should be reassured by the fact that many development programs are strongly underway investigating novel approaches to treat back-of-the-eye disorders. Drs. Dunn and Sheth's insights will be highly valued by our community.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3928/23258160-20170130-02

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 70

Metadata

Authors
Dunn, E. N., Sheth, V. S., & Hariprasad, S. M.
Venue
Ophthalmic Surgery, Lasers and Imaging Retina
Publisher
SLACK, Inc.
Published
2017-02
Volume
48
Issue
2
Pages
100-104
ISSN
  • 1542-8877 (ISSN-L)
  • 2325-8160
  • 2325-8179
OpenAlex
W2589033892
Cited by
70
References
6
FWCI
7.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. https://app.cochat.ai/papers/10.3928/23258160-20170130-02
The paper
Dunn, E. N., Sheth, V. S., & Hariprasad, S. M. (2017). An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications. Ophthalmic Surgery, Lasers and Imaging Retina. https://doi.org/10.3928/23258160-20170130-02

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.